[May 26, 2016]

Global Ageing Pipeline Report 2016 - Therapeutics Review of 6 Companies & Drug Profiles - Research and Markets

Research and Markets has announced the addition of the "Ageing - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Ageing , complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ageing and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelins by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. Ageing Overview
3. Therapeutics Development
4. Pipeline Products for Ageing - Overview
5. Pipeline Products for Ageing - Comparative Analysis
6. Ageing - Therapeutics under Development by Companies
7. Ageing - Therapeutics under Investigation by Universities/Institutes
8. Ageing Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Ageing - Products under Development by Companies
13. Ageing - Products under Investigation by Universities/Institutes
14. Ageing - Companies Involved in Therapeutics Development

• Araim Pharmaceuticals, Inc.
• Bioo Therapeutics
• Mapreg S.A.S.
• RepliCel Life Sciences, Inc.
• RXi Pharmaceuticals Corporation
• Theravasc, Inc.

For more information visit http://www.researchandmarkets.com/research/z5txt7/ageing_pipeline

View source version on businesswire.com: http://www.businesswire.com/news/home/20160526006181/en/

[ Back To TMCnet.com's Homepage ]